Drug Type Small molecule drug |
Synonyms ANAVEX-1519 |
Target |
Action modulators, antagonists |
Mechanism ENaC modulators(Epithelial sodium channel modulators), σ1 receptor antagonists(Sigma opioid receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neuralgia | Preclinical | United States | - | |
Ovarian Cancer | Preclinical | United States | - | |
Pancreatic Cancer | Discovery | United States | - |